心力衰竭与全髋关节置换术后早期内科及手术相关并发症相关:一项倾向性评分分析
基于大型全国保险数据库的倾向性评分匹配分析显示,合并心力衰竭的全髋关节置换患者术后90天内肺栓塞、深静脉血栓、输血、肺炎、脑血管意外、心肌梗死、脓毒症、急性出血性贫血、急性肾衰竭和尿路感染发生率更高,1年翻修、假体周围感染、无菌性松动和脱位风险也更高,且急诊就诊、再入院、住院时间和1年费用增加;术前1年使用心衰获益药物的患者术后90天内肺栓塞、深静脉血栓、脑血管意外、急诊就诊、再入院和心肌梗死风险及1年翻修和无菌性松动风险降低。
要点
- 合并心衰的全髋关节置换患者术后90天内内科和手术相关并发症发生率更高。
- 合并心衰的全髋关节置换患者1年翻修、假体周围感染、无菌性松动和脱位风险更高。
- 术前1年使用心衰获益药物与术后90天内部分内科并发症及1年翻修和无菌性松动风险降低相关。
核心结论
- 合并心力衰竭的患者在全髋关节置换术后早期内科和手术相关并发症风险增加。
- 这些发现可能有助于对计划接受全髋关节置换的心衰患者进行更好的风险分层,并呼吁在术后近期和早期加强监测。
研究设计与样本
- 利用大型全国保险数据库识别2010年至2019年间接受初次全髋关节置换的心衰患者。
- 倾向性评分匹配后纳入34,000例心衰患者和340,000例匹配对照患者。
- 评估术后90天内各种内科并发症、手术相关并发症和住院资源利用情况,并对术前1年接受心衰获益药物治疗的患者进行亚组分析。
主要发现
- 心衰队列与对照组相比,90天内肺栓塞、深静脉血栓、输血、肺炎、脑血管意外、心肌梗死、脓毒症、急性出血性贫血、急性肾衰竭和尿路感染发生率更高。
- 心衰队列与对照组相比,1年翻修全髋关节置换、假体周围感染、无菌性松动和脱位风险更高。
- 心衰队列与对照组相比,90天内急诊就诊、再入院、住院时间和1年医疗费用更高。
- 药物队列与未使用药物者相比,术后90天内肺栓塞、深静脉血栓、脑血管意外、急诊就诊、再入院和心肌梗死风险降低,1年翻修全髋关节置换和无菌性松动风险降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There is a paucity of literature that examines how heart failure (HF) impacts surgery-related complications following total hip arthroplasty (THA). We hypothesized that patients who had HF will be at increased risk of early medical- and surgery-related complications following THA. METHODS: Patients who had HF and underwent primary THA between 2010 and 2019 were identified using a large national insurance database. Ninety-day incidence of various medical complications, surgery-related complications, and hospital utilizations were evaluated for patients who did and did not have HF, as well as subgroup analyses were performed on patients who were prescribed mortality-benefitting medications for HF 1 year prior to THA. Propensity score matching resulted in 34,000 HF patients who underwent primary THA and 340,000 matching patients. RESULTS: The HF cohort was associated with a higher 90-day incidence of pulmonary embolism (PE), deep vein thrombosis (DVT), transfusion, pneumonia, cerebrovascular accident (CVA), myocardial infarction (MI), sepsis, acute post hemorrhagic anemia, acute renal failure (ARF), and urinary tract infection (UTI), as well as 1-year risk of revision THA, periprosthetic joint infection (PJI), aseptic loosening, and dislocation compared to controls. The HF cohort was associated with a higher 90-day incidence of emergency department visits, readmissions, lengths of stay (LOS), and 1-year costs of care. The medication cohort was at decreased risk of PE, DVT, CVA, return to ED, readmission and MI within 90 days of surgery, and 1-year risk of revision THA and aseptic loosening. DISCUSSION: These findings may help to better risk-stratify patients who have HF and are scheduled to undergo THA, as well as call for additional surveillance of these patients in the immediate and early postoperative period. This study also helps surgeons and internists understand how chronic medications used to treat HF can impact medical- and surgery-related outcomes following THA.
引用
- Sequeira SB, Boucher HR. Heart Failure is Associated with Early Medical and Surgery-Related Complications Following Total Hip Arthroplasty: A Propensity-Scored Analysis. J Arthroplasty. 2022. PMID: 36470365. doi:10.1016/j.arth.2022.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。